E. Baltes - Concepedia

Author

E. Baltes

UCB Pharma (Belgium)

Also Known As

E BALTES, E Baltes, E L Baltes, E. Baltes, E.L. Baltes, Eug�ne Baltes

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

UCB Pharma (Belgium)UCB Pharma (France)

About

E. Baltes is an author at UCB Pharma (Belgium) specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	383
2	Allergy	2	2	102
3	Allergy Medicine	2	2	102
4	Engineering	1	1	46
5	Biomedical Engineering	1	1	46

E. Baltes

Publications

596

Citations

H-Index

Page 1

	Year	Citations
A randomized, double‐blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine‐induced cutaneous responses in healthy adult volunteers J.L. Devalia, F. Hanotte, E. Baltes, Allergy	2001	150
Pharmacokinetics and metabolism of 14 C-levetiracetam, a new antiepileptic agent, in healthy volunteers M. Strolin Benedetti, Rhys Whomsley, Jean‐Marie Nicolas, European Journal of Clinical Pharmacology Pharmacological StudyMedicineHealthy VolunteersPharmacotherapyNeurology	2003	104
Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers René H. Levy, Isabelle Ragueneau‐Majlessi, E. Baltes Epilepsy Research MedicineHealthy VolunteersPsychotropic MedicationClinical PharmacologyPharmacotherapy	2001	63
Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines Michel Gillard, M. Strolin Benedetti, Pierre Chatelain, Inflammation Research AllergyAllergy MedicineMedicineImmunologySecond Generation H1-antihistamines	2005	63
Comparative pharmacokinetics and metabolism of levetiracetam, a new anti-epileptic agent, in mouse, rat, rabbit and dog M. Strolin Benedetti, René Coupez, Rhys Whomsley, Xenobiotica	2004	63
Absence of Pharmacokinetic Drug Interaction of Levetiracetam with Phenytoin in Patients with Epilepsy Determined by New Technique T. R. Browne, G. Szabó, Ilo E. Leppik, The Journal of Clinical Pharmacology Molecular PharmacologyNew TechniqueTherapeutic Drug MonitoringMedicineEpilepsy Determined	2000	56
Peroral Sustained-Release Film-Coated Pellets as a Means to Overcome Physicochemical and Biological Drug-Related Problems. I. In Vitro Development and Evaluation Karim Amighi, Johan Timmermans, J. Puigdevall, Drug Development and Industrial Pharmacy Edible FilmEngineeringBiomedical EngineeringVitro Preformulation TestingDissolution Rate	1998	46
Inhibition of histamine and allergen skin wheal by cetirizine in four animal species. Christine De Vos, M.-R. Maleux, E. Baltes, PubMed Allergy MedicineAllergenSkin AllergyPharmacotherapyDermatology	1987	39
Absence of Pharmacokinetic Drug Interaction of Levetiracetam with Phenytoin in Patients with Epilepsy Determined by New Technique T.R. Browne, G.K. Szabo, I.E. Leppik, The Journal of Clinical Pharmacology Molecular PharmacologyNew TechniqueMedicineEpilepsy DeterminedPsychotropic Medication	2000	12

Page 1